November 15 (SeeNews) - Slovenian pharmaceutical products wholesaler Salus [LJE:SALR] said on Friday it recorded a consolidated net profit of 10.18 million euro ($10.7 million) in the first nine months of 2024, up from 7.36 million euro in the like period of last year, it said.